COVID-19 vaccine updates are here. The Indian government is at work to prepare a successful and efficient antidote for the coronavirus. The coronavirus pandemic has infiltrated the world economy since the beginning of 2020. The worst attacks on the global economy posed a permanent risk to economics. With the opening of the restrictions, the economies have started recovering. However, we cannot say the same for health. The virus is still looming at large. The scientists all across the world have been busy developing the best medicine for it. The Bharat Biotech has also been busy with developing Covaxin. The updates for the ministry of Health says that the Center estimates at rendering 25 crore people with a vaccine in their hands by mid-2021.
COVID-19 vaccine updates: Not everyone will get a vaccine in 2021
That is the major news for the entire nation. Where the health officials spoke of the good news for only 20-25 crore Indians, they also mentioned that this means others will have to wait further. Formulating the 400-500 million doses cost up to Rs. 50,000 crore. The doses will end with the selected people. Then, the rest of the nation will have to wait another year or two for the shot. Health Minister Harsh Vardhan stated that The National Democratic Alliance plans on utilizing the said doses of vaccine to about 200-250 million people by july 2021.
Other than Bharat Biotech’s Covaxin, Cadila Healthcare Ltd. is testing out ZyCov-D, as well. The studies in the process right now aim at improving the safety and immunogenicity of the Indian population. However, these studies can “end quickly”. Harsh Vardhan further spoke on the Russian vaccine Sputnik V, which is done in collaboration with Russia. He said, “No decision has been taken yet on the Phase 3 trials and it is under consideration.”
The trials process will have proper facilities
Harsh Vardhan assured people that only those vaccines will proceed to the trial phase which have the confidence of the developers. If scientists do not feel confident about it, they will not launch it among the public. He said, “India has robust processes to ensure the vaccines that complete trials that are safe and effective. When conducted, abundant forethought, caution, and oversight will be ensured. As per global experience, India will only venture into safe area trials.”
He shunned the rumors of exposing people to the virus to test the legitimacy of the vaccine. The trials will strictly follow the rules and regulations of DCGI. He further addressed the public to reinstate the importance of wearing masks and keeping hands clean. The vaccines when given out may cause mild irritation like redness and localized pain. The fight against the coronavirus is universal. The COVID-19 vaccine updates always instill a ray of hope in all of us.